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Abstract
Exposure to inorganic arsenic (InAs) via drinking water and/or food is a con-
siderable worldwide problem. Methylation of InAs generates monomethyl
(MMAsIII+V)- and dimethyl (DMAsIII+V)-arsenical species in a process that
facilitates urinaryAs elimination; however,MMAs is considerablymore toxic
than either InAs or DMAs. Emerging evidence suggests that incomplete
methylation of As to DMAs, resulting in increased MMAs, is associated
with increased risk for a host of As-related health outcomes. The biochem-
ical pathway that provides methyl groups for As methylation, one-carbon
metabolism (OCM), is influenced by folate and other micronutrients, in-
cluding choline and betaine. Individuals and species differ widely in their
ability to methylate As. A growing body of research, including cell-culture,
animal-model, and epidemiological studies, has demonstrated the role of
OCM-related micronutrients in As methylation. This review examines the
evidence that nutritional status and nutritional interventions can influence
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1. INTRODUCTION
Arsenic (As) is a naturally occurring element that is relatively ubiquitous in insoluble forms in
soil. However, As in soil can be mobilized, leading to enrichment of As in groundwater (160).
Ingested inorganic As (InAs) undergoes hepatic methylation in a process that relies on one-carbon
metabolism (OCM), a biochemical pathway that is dependent on folate and other micronutrients.
This article provides a brief overview of As exposure and As metabolism, including what is known
about the influence of As methylation on As elimination, As toxicity, and risk for As-related
health outcomes.We then focus on summarizing the evidence from human studies indicating that
nutritional status and nutritional interventions that influence OCM can increase As methylation
capacity and potentially reduceAs toxicity in at-risk populations, with a primary emphasis on folate.
1.1. Arsenic Exposure
TheWorld Health Organization (WHO) estimates that over 200 million people in more than 70
countries are exposed to As in drinking water at concentrations greater than 10 μg/L, the WHO
guideline and US Environmental Protection Agency (EPA) maximum contaminant level (165).
Among the most severely affected countries are Bangladesh, Cambodia, China, India, Myanmar,
Nepal, Pakistan, Taiwan, Argentina, and Vietnam (125). Collectively, these countries bear a high
proportion of the global burden of As-related morbidity and mortality. In Bangladesh, exposure
to As through drinking water began in the 1970s, when UNICEF and other nongovernmental
organizations advocated amassive switch from drinkingmicrobially contaminated surface water to
groundwater in an effort to reduce infantmortality due to diarrheal disease.Unfortunately, 20 years
passed before it was discovered that the groundwater is contaminated with naturally occurring As,
with concentrations ranging from nondetectable to levels exceeding 1,000 μg/L (132).
In the United States, As concentrations in groundwater are elevated in areas of the West,
Midwest, and Northeast (7). It is estimated that at least five million people are exposed
to As-contaminated water in the United States owing to technical challenges that prevent
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implementation of the drinking water standard and to the use of private wells, which are not
covered by the EPA regulations (44).
While the predominant source of exposure to As worldwide is through drinking water, the
ingestion of As through As-contaminated beverages (such as apple juice and some red wines) and
foods (particularly rice and rice products) can contribute to a relatively large proportion of exposure
in regions where drinking water As concentrations are low (34, 162). Arsenic concentrations in
selected foods and beverages surveyed by the US Food and Drug Administration (FDA) and EPA
are presented in Table 1 (for a more comprehensive list of As concentrations in common foods,
see 45–47).
In the United States, As contamination in rice is primarily the result of growing rice in fields
that were previously used to grow cotton treated with InAs as a pesticide to eliminate cotton-eating
boll weevils (11, 122). Rice species grown in these fields were selected for their ability to grow
heartily in As-pesticide-treated soil (161).
Exposure to As through food varies between ethnicities, largely depending on ethnic patterns
of rice consumption (45). The concentration of As in rice varies widely, ranging from less than the
limit of detection to as high as 1.8μg/g in uncooked rice (45, 64, 67, 102).MostAs in rice is InAsIII+V
or dimethylarsinic acid (DMAsV). The latter is a relatively less toxic form of As understood to
arise from soil microbiotic processes (161). Rice-based products are also sources of As, including
cereals, crackers, rice drinks, and rice syrup–sweetened products such as baby formulas and energy
bars (76, 148). Brown rice and brown rice products have higher concentrations of InAs because it
accumulates in the aleurone layer of the grain, which is removed when rice is refined. In contrast,
DMAs can pass into the rice grain directly (21). When rice or rice bran is cooked in an excess of
As-freewater and then drained, up to 80%of the InAsmay be removed, though if As-contaminated
water is used, the As burden may be increased (22, 64, 130).
There is particular concern regarding As exposure in infants and children through food
and beverages. Risk assessments conducted by the FDA found average InAs concentrations of
105 ppb in infant white rice cereal and average total As concentrations of 5 μg/L in apple juice
(45). Due to a higher per-body-mass food intake and a more limited diet, infants and young chil-
dren have significantly higher relative InAs intake than adults (45). While there are currently no
FDA regulations regarding As concentrations in food, the FDA monitors As concentrations and
has proposed an action level for InAs in infant rice cereal of 100 ppb (45).
Additional food-based sources of exposure may include chicken grown with the feed additive
Roxarsone (currently banned in the United States) (108), as well as wheat (176). Although seaweed
and seafood, including shellfish, are also sources of exposure, As from these sources is largely in
the form of arsenobetaine and arsenocholine, which are nontoxic arsenicals (16, 110).
1.2. Health Effects of Arsenic
Arsenic is a Group 1 human carcinogen and toxicant that affects numerous organs and systems
(3). Chronic As exposure increases the risk of health conditions including skin lesions (melanosis,
leukomelanosis, and keratosis); cardiovascular disease; impaired intellectual function; inflamma-
tion; diabetes; and cancers of the bladder, lung, kidney, liver, skin (109), and possibly prostate
(Figure 1) (12). In Taiwan, chronic As exposure has been associated with blackfoot disease, a pe-
ripheral vascular disease linked to systemic atherosclerosis and dry gangrene (154). Arsenic-related
health risks persist after exposure has ended or been reduced. Several studies in Northern Chile,
where people were exposed to highly As-contaminated drinking water for a very distinct temporal
period, have demonstrated that exposure isolated to infancy or early life results in an elevated
lifetime risk of As-related health outcomes such as lung and bladder cancer (133, 142, 145).
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Table 1 Summary of selected dietary sources of arsenic exposure
Arsenic source Reference Sample Arsenic concentration range
Brown rice (includes basmati,
jasmine, long/medium/short
grain, instant)
FDA (45) Commercially available and
supplied by the USA Rice
Federation, FDA sampling, 2013
(N= 144)
Total As: 57–854 ppb




White rice (includes basmati,
jasmine, long/medium/short
grain, instant)
FDA (45) Commercially available and
supplied by the USA Rice
Federation, FDA sampling, 2013
(N= 429)
Total As: 40–776 ppb




Infant brown rice cereal FDA (45) Commercially available, FDA
sampling, 2013 and 2016 (N= 59)
InAs: 30–254 ppb (mean: 119.9 ppb)
Infant white rice cereal FDA (45) Commercially available, FDA
sampling, 2013 and 2016 (N= 86)
InAs: 21–151 ppb (mean: 105.3 ppb)
Toddler/infant rice cereal FDA (45) Commercially available, FDA
sampling, 2016 (N= 82)
Total As: 18.0–224 ppb (mean: 124 ppb)
InAs: 20.8–126 ppb (mean: 97.8 ppb)
MMAs: 4.4–4.8 ppb (mean: 4.6 ppb)
DMAs: 3.3–94.2 ppb (mean: 30.5 ppb)
Infant formula FDA (45) Commercially available, FDA
sampling, 2013 (N= 10)
Total As: 1–2 ppb (mean: 1 ppb)
InAs: 0–1 ppb (mean: 1 ppb)
Rice cereal (includes hot and
ready-to-eat)
FDA (45) Commercially available, FDA
sampling, 2013 (N= 110)
Total As: 50–810 ppb (mean: 176 ppb)
InAs: 20–545 ppb (mean: 100 ppb)
MMAs: 3–14 ppb (mean: 6 ppb)
DMAs: 7–493 ppb (mean: 63 ppb)
Rice cakes FDA (45) Commercially available, FDA
sampling, 2013 (N= 59)
Total As: 32–620 ppb (mean: 255 ppb)
InAs: 23–273 ppb (mean: 145 ppb)
MMAs: 5–17 ppb (mean: 9 ppb)
DMAs: 15–477 (mean: 123 ppb)
Meal replacement/energy bars FDA (45) Commercially available, FDA
sampling, 2013 (N= 29)
Total As: 10–130 ppb (mean: 68 ppb)
InAs: 5–98 ppb (mean: 50 ppb)
MMAs: <LOD
DMAs: 6–28 ppb (mean: 13 ppb)
Rice beverages FDA (45) Commercially available, FDA
sampling, 2013 (N= 42)
Total As: 6–320 ppb (mean: 109 ppb)
InAs: 1–278 ppb (mean: 60 ppb)
MMAs: <LOD
DMAs: 5–85 ppb (mean: 28 ppb)
Apple juice FDA (47) EPA Toxic Elements Program,
2005–2011; Apple Juice Survey,
2011 (N= 144)
Total As: <LOD–45 ppb (mean: 7.2 ppb)
Apple juice concentrate FDA (47) EPA Toxic Elements Program
2005–2011 (N= 103)
Total As: <LOD–34 ppb (mean: 2.6 ppb)
Red wine FDA (46) FDA Total Diet Study program,
2006–2013 (N= 32)
Total As: <LOD–24 ppb (mean: 8 ppb)
Abbreviations: DMAs, dimethyl-arsenical species; FDA, US Food and Drug Administration; EPA, US Environmental Protection Agency; InAs, inorganic
arsenic; LOD, limit of detection; MMAs, monomethyl-arsenical species.

















































































































Arsenic metabolism, target tissues, and comorbidities. Chronic As exposure has been associated with increased risk of skin lesions
(melanosis, leukomelanosis, and keratosis), cardiovascular disease, hypertension, impaired intellectual function, inflammation, diabetes,
and cancers. Ingested As accumulates in multiple tissues, including the spleen, liver, lungs, kidneys, bladder, skin, and bone marrow.
(Inset) AS3MT is predominantly expressed in the liver, although AS3MT mRNA has also been detected in the kidneys, adrenal gland,
bladder, heart, and brain (92). Abbreviations: AS3MT, arsenic-3-methyltransferase; DMAsV, dimethylarsinic acid; InAsIII, arsenite;
MMAsIII, monomethylarsonous acid; MMAsV, monomethylarsonic acid; SAH, S-adenosylhomocysteine; SAM, S-adenosylmethionine.
1.3. Arsenic Methylation and Elimination
Arsenic in drinking water is predominantly inorganic arsenate (InAsV) or arsenite (InAsIII), but
once ingested, it undergoes methylation in a process that facilitates urinary As elimination (20).
In 1945, Challenger reported a model in which InAs undergoes alternate reduction and oxidative
methylation reactions (24), illustrated in Figures 1 and 2. Briefly, InAsIII is methylated by
arsenic-3-methyltransferase (AS3MT) (92), using S-adenosylmethionine (SAM) as the methyl



















































































































Arsenic metabolism. In the Challenger pathway (24), AS3MT catalyzes the oxidative methylation of arsenite using SAM as the methyl
donor, forming MMAsV and SAH. MMAsV is then reduced to MMAsIII before a subsequent oxidative methylation step, yielding
DMAsV and SAH. Abbreviations: AS3MT, arsenic-3-methyltransferase; DMAsV, dimethylarsinic acid; MMAsIII,
monomethylarsonous acid; MMAsV, monomethylarsonic acid; SAH, S-adenosylhomocysteine; SAM, S-adenosylmethionine.
donor, to form monomethylarsonic acid (MMAsV) (24, 151). MMAsV is then reduced to
monomethylarsonous acid (MMAsIII), an intermediate with very high cytotoxicity and genotox-
icity (117, 118, 147). MMAsIII is subsequently methylated by AS3MT to form dimethylarsinic
acid (DMAsV) (24, 92, 151). DMAsV is rapidly excreted in urine and is considerably less toxic
than MMAsIII, InAsIII, or InAsV (147). While other identified methyltransferase enzymes are
capable of methylating As (171, 172), AS3MT catalyzes these methylation reactions with a Km
in the nanomolar range, indicating that it is the most physiologically relevant enzyme for As
methylation (92). Glutathione (GSH) may increase the speed of the reduction steps, influence
the activity of AS3MT, and sequester As. Hayakawa et al. (62) proposed a pathway in which
As–GSH complexes are substrates for AS3MT. Using a mathematical model based on the known
biochemistry of As derived from cellular and experimental studies, our group found that the
Challenger pathway of As methylation, along with the GSH effects, is sufficient to understand
and predict experimental data (87). Additional experimental studies are needed to determine the
relative roles that alternative pathways play in As methylation.
AS3MT is predominantly expressed in the liver, but AS3MT mRNA has also been detected
in the kidneys, adrenal gland, bladder, heart, and brain (92). Work by Thomas’s group (39, 74)
using AS3MT knockout mice illustrates the profound role of AS3MT in As elimination, as mice
deficient in AS3MT accumulate a body burden of As that is 16–20 times greater than wild-type
mice and exhibit severe systemic toxicity and early death.
There are controversies surrounding the influence of As metabolism on toxicity owing in part
to analytical challenges. For example, because trivalent arsenicals are readily oxidized to pentava-
lent forms by environmental oxygen, it is difficult to distinguish between the valence states of As
metabolites, and the potential for artifact is high. Because of this limitation,most human studies re-
port the percentages of total As as%InAsIII+V,%MMAsIII+V, and%DMAsIII+V. Some studies have
provided conflicting information about the portion of DMAsV versus DMAsIII that may be present
in urine (36, 98, 157). This reported discrepancy may be due to the high reactivity of DMAsIII,
which can be rapidly oxidized to DMAsV (82). Additionally, one chromatographic protocol that
treats DMAsV with metabisulfite and thiosulfate can inadvertently generate thio-DMAsV (61), a
relatively minor arsenical species (5% of total As) that has been identified in human urine (124).
1.4. Arsenic Methylation and Toxicity
Arsenic metabolites vary considerably in their toxicity. Trivalent arsenicals have greater cytotoxi-
city and genotoxicity than pentavalent forms. Using real-time cell sensing in two human cell lines,
Le’s group (105), in agreement with the work of others (117), reported that MMAsIII is the most
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Figure 3
Summary plot of odds ratios and 95% CI for health outcomes reported to be associated with %MMAs in urine (2, 26–28, 54, 72, 89–91,
94, 97, 103, 123, 140, 144, 153, 166, 170). Abbreviations: %MMAs, percent monomethyl-arsenical species; CI, confidence interval.
cytotoxic As metabolite, followed by DMAsIII, InAsIII, InAsV, MMAsV, DMAsV, and the chicken
feed additive Roxarsone. Studies utilizing hamster cells from a variety of tissues including kidney
and heart demonstrate that MMAsIII is the most cytotoxic arsenical species in all cell types tested
(118). In epidemiological studies, a higher percentage of MMAsIII+V in urine has been associated
with increased risk for bladder, breast, lung, and skin cancer, as well as skin lesions, peripheral
vascular disease, atherosclerosis (Figure 3), and decreased birthweight (2, 27, 28, 54, 70–72, 85,
94, 97, 103, 123, 140, 144, 153, 166, 170). In contrast, the risk of metabolic syndrome and dia-
betes has been negatively associated with %MMAs in urine (26, 83). Most, but not all, of these
studies used prevalent cases and therefore cannot establish temporality or rule out the possibility
of reverse causation, i.e., that having a disease influences the ability to methylate As. However, in
a recent nested case-control study of As-induced skin lesions, we found that participants falling
into the lowest tertile of %DMAs in urine were at higher risk for development of skin lesions
2–7 years later (113).
Arsenic methylation capacity differs between species, individuals, and populations. In
Bangladesh, members of our group have found that genetic variation in the AS3MT gene is a
strong genetic predictor of As methylation capacity (52, 77). Single-nucleotide polymorphisms
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(SNPs) in AS3MT have also been associated with the proportion of As metabolites in urine in
other populations (1, 9, 41, 65, 66), as well as As-related health outcomes such as skin lesions and
skin cancer (43, 52). In addition, epigenetic regulation may influence As methylation capacity.
In a study of Argentinean women, the AS3MT haplotype was found to be associated with the
methylation status of the AS3MT gene—which influenced AS3MT gene expression—and with As
methylation capacity (42).
1.5. Tissue Distribution of Arsenic
Early studies in rats, rabbits, and mice have shown that As accumulates in the spleen, liver, lungs,
kidneys, bladder, skin, and bone marrow when administered orally (Figure 1) (14, 35, 75, 99,
146). While tissue As concentrations are difficult to study in humans, a case study of suicide by
As trioxide poisoning demonstrated that following an acute high oral dose of As, concentrations
were highest in the liver and kidneys; moderate in the muscles, heart, spleen, pancreas, lungs, and
brain; and lowest in the skin (13). Under steady-state conditions of low-dose chronic exposure,
As distribution is likely different. In a postmortem study of human tissues from individuals living
in Bombay, Dang et al. found As concentrations to be more than 20 times higher in hair than in
other tissues including the liver, kidneys, brain, lungs, and spleen (33). Yamauchi & Yamamura
reported As concentrations from human cadavers in Japan that lacked high premortal occupational
or environmental As exposure; they found concentrations in the liver, kidneys, pancreas, and skin
slightly elevated relative to the lungs, muscles, and spleen (169). The accumulation of As in hair
and skin is due to the affinity of As for keratin, a cysteine-rich protein that is abundant in squamous
epithelia (95).
Arsenic exposure and methylation patterns in human studies are most often assessed in urine
because As concentrations in urine are an order of magnitude higher than in blood, but over
the past decade, analytical advances have allowed our group’s Trace Metals Core laboratory to
measure As and its methylated metabolites in blood. While the concentrations of As metabolites
in blood are highly correlated with those in urine (Spearman correlation coefficients range from
ρ = 0.68 to ρ = 0.81), the relative distribution is strikingly different (51). Because DMAs is more
rapidly excreted in urine, the %DMAs in blood is lower and the %MMAs is higher than in urine.
For example, in baseline samples from our first folic acid (FA) trial, the mean distributions of
As in urine versus blood were 15% versus 26% for InAs, 13% versus 40% for MMAs, and 72%
versus 34% for DMAs (51). Maternal concentrations of As and As metabolites in blood are highly
correlatedwith those of umbilical cord blood, with Spearman correlation coefficients ranging from
ρ = 0.80 to ρ = 0.94 (P< 0.0001), indicating that fetal As exposure mimics that of the mother (57).
The extent to which urinary and/or blood As metabolite distributions reflect their distributions
in target tissues in humans is unknown. The use of in silico experiments (described in Section 3.5)
can begin to give insight on As distribution in tissue compartments.
1.6. Mechanisms of Action of Arsenic
The carcinogenic and noncarcinogenic mechanisms of action of As are incompletely understood
and are likely multifactorial. InAs and its metabolites are poor mutagens (81). The carcinogenic
mechanisms of As may involve inhibition of DNA repair, disruption of the cell cycle, alterations
in gene expression via DNA methylation and histone modifications, inhibition of thymidylate
synthesis, endocrine disruption, and/or oxidative stress (55, 78, 107, 114, 127, 167). A similar
battery of mechanisms is likely involved in the etiology of other As-induced diseases (131). Here,
we briefly summarize those mechanisms having the most supporting evidence.
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1.6.1. Protein binding. Arsenic is known to bind to and inhibit many enzymes (25, 177). InAs
is an extremely reactive metalloid, and toxicity of AsIII is in part attributable to its ability to react
with critical sulfhydryl groups ofmany enzymes. Arsenicmetabolites differ in their protein binding
capacity; there are three coordination sites on InAsIII, two on MMAsIII, and only one on DMAsIII
(4). Binding of As to two sulfhydryl groups in the active site of a single protein can yield a stable
structure and lead to irreversible enzyme inhibition (4).
1.6.2. Oxidative stress. Reactive oxygen species (i.e., oxygen-containing radicals, oxidizing
agents, and species readily transformed into radicals) contribute to cancer development by produc-
ing DNA alterations and interfering with signal transduction and protein activity (163). In animal
models and studies of human cell cultures, As exposure has been associated with the formation of
8-hydroxy-2′-deoxyguanosine, a marker of DNA oxidative stress (168). Effects differ between As
species and valence states; e.g., treatment of human keratinocytes with InAsIII generated reactive
oxygen species to a greater extent than treatment with InAsV (38). Furthermore, in the Folate
and Oxidative Stress (FOX) study, a cross-sectional study of As-exposed adults in Bangladesh,
our group demonstrated that water As was associated with significant decreases in blood GSH, a
strong endogenous antioxidant (60).
1.6.3. Epigenetic dysregulation. Many of the health effects of As exposure persist even after
exposure has ended, and exposure in early life increases the risk of diseases later in life (142,
143, 145). Evidence from studies in animals and human cells strongly suggests that epigenetic
dysregulation is involved in the etiology of diseases associated with As exposure (e.g., 32, 158).
The association between As exposure and epigenetics has been reviewed elsewhere (5, 68, 127).
Briefly, cell-culture studies show that As exposure induces genome-wide DNA hypomethylation,
which likely contributes to As-induced genomic instability (100). Arsenic exposure has also been
associated with changes in global DNA methylation, loci-specific DNA methylation, global 5-
hydroxymethylcytosine (an intermediate product of DNA demethylation), and histone modifica-
tions in animal models and epidemiological studies (69, 112, 155, 175). Arsenic affects methylation
patterns of genes associated with chronic illnesses (such as diabetes), suggesting that As exposure
may influence gene expression involved in the onset of these diseases (8). In several studies of
As-exposed adults in Bangladesh, we have found that As was positively associated with global
DNA methylation of peripheral blood mononuclear cell DNA, and the association between As
exposure and global DNA methylation was modified by folate, a potential compensatory mecha-
nism to prevent hypomethylation (111, 119, 120). Limited research has evaluated the association
between As exposure and epigenome-wide blood DNA methylation profiles using the Illumina
450K BeadChip (6, 17, 80, 129). The largest study to date, conducted on skin lesion cases in
Bangladesh (N= 400), showed that As exposure was associated with four CpG sites that passed
the Bonferroni significance threshold (P< 1× 10−7), and these results were replicated in a second
smaller Bangladeshi study population (6).
2. NUTRITIONAL INFLUENCES ON ONE-CARBON METABOLISM
Methylation reactions are dependent on the methyl donor SAM, a critical cosubstrate in OCM
(Figure 4). Several micronutrients including folate, vitamin B12 (cobalamin), betaine, choline,
riboflavin, and vitamin B6 (pyridoxal phosphate) play critical roles in OCM. FA is a synthetic
form of folate used in food fortification. FA must be reduced to 5-methyltetrahydrofolate (5-
methyl-THF) by dihydrofolate reductase to become metabolically active in OCM. In the fo-
late cycle, a one-carbon unit is transferred from serine to tetrahydrofolate (THF) to form
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One-carbon metabolism. FA, arising from fortified foods or nutritional supplements, is reduced to DHF and THF by dihydrofolate
reductase. Serine hydroxymethyl-transferase transfers one-carbon units from serine to THF, with PLP as a coenzyme, forming
5,10-methylene-THF. This is either used for the synthesis of thymidylate or reduced to 5-methyl-THF. Dietary folates can enter
one-carbon metabolism as 5-methyl-THF. The methyl group of 5-methyl-THF is transferred to homocysteine in a reaction catalyzed
by MTR and utilizing B12 as a cofactor, generating methionine and THF. Alternatively, in the liver, betaine can donate a methyl group
for the remethylation of homocysteine in a reaction catalyzed by BHMT. Methionine adenosyltransferase enzymes activate methionine
to form SAM—the methyl donor for numerous acceptors, including arsenicals, GAA (the precursor to creatine), and DNA—in
reactions that involve substrate-specific methyltransferase enzymes. These methylation reactions generate the methylated products and
SAH, a potent product inhibitor of most methyltransferases. SAH is hydrolyzed to generate homocysteine, which is either
remethylated to regenerate methionine or directed to the transsulfuration pathway and ultimately glutathionine synthesis.
Abbreviations: AS3MT, arsenic-3-methyltransferase; BHMT, betaine homocysteine methyltransferase; DHF, dihydrofolate; DMAsV,
dimethylarsinic acid; DNMT, DNA methyltransferases; FA, folic acid; GAA, guanidinoacetate; GAMT, guanidinoacetate-N-
methyltransferase; InAsIII, arsenite; MMAsIII, monomethylarsonous acid; MMAsV, monomethylarsonic acid; MRP, multidrug
resistance proteins; MTR, methionine synthase; PCFT, proton coupled folate transporter; PLP, pyridoxal phosphate; SAH,
S-adenosylhomocysteine; SAM, S-adenosylmethionine; SLC19A1, solute carrier family 19 (folate transporter), member 1, also known
as RFC1; THF, tetrahydrofolate; TS, thymidylate synthetase.
5,10-methylene-THF, which is subsequently reduced to 5-methyl-THF by methylene tetrahy-
drofolate reductase (MTHFR). 5-Methyl-THF is the predominant naturally occurring form of
folate from dietary sources (30). In a reaction catalyzed by methionine synthase, the methyl group
of 5-methyl-THF is transferred to homocysteine (Hcy) utilizing B12 as a cofactor, to gener-
ate methionine and THF. Betaine is an alternative methyl donor that can be obtained in the
diet or synthesized from choline. Methionine adenosyltransferase enzymes activate methionine
to form SAM, the universal methyl donor for hundreds of transmethylation reactions (40). All of
thesemethylation reactions generate themethylated product and S-adenosylhomocysteine (SAH),
which is hydrolyzed to Hcy in a reaction that is readily reversible. This point is important because
SAH is a potent product inhibitor of most methylation reactions, and 5-methyl-THF plays an
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essential role in pulling the pathway forward. Despite the fact that multiple micronutrients in-
fluence OCM, folate nutritional status appears to be the primary determinant of circulating Hcy
concentrations in most studies of adults. For example, in a cross-sectional survey, we observed a
high prevalence of high Hcy in Bangladesh, and plasma folate and B12 were found to explain 15%
and 5% of the variance in Hcy, respectively (48).
3. NUTRITIONAL INFLUENCES ON ARSENIC METHYLATION
3.1. OCM and Arsenic Metabolism in Animal Models
Early studies in animalmodels provided experimental evidence that nutritional regulation ofOCM
influences the methylation and toxicity of As. In 1987, Vahter & Marafante (156) reported that
rabbits fed diets deficient inmethyl donors (methionine, choline, or protein) had significantly lower
urinary excretion of total As and DMAs, and increased As retention in tissues; similar results were
reported by others in mice (152). Finnell’s group conducted an elegant series of studies on neural
tube defects (NTDs) that employed mice nullizygous for several folate-binding proteins involved
in cellular uptake of folate from the circulation (e.g., Folbp-1 and -2) and/or enterocytes (reduced
folate carrier). Mice were injected with sodium arsenate early in gestation during critical periods
for neural tube closure. For all genotypes studied, dietary folate deficiency caused a reduction in
urinary excretion of DMAs, and Folbp-2 null mice were more susceptible to As-induced NTDs
(134–136, 164).While As exposure has not yet been solidly linked to NTD risk in humans, studies
are under way, and a recent study in Bangladesh reported that As exposure reduced the efficacy of
FA in preventing NTDs (101).
The utility of rodent models in understanding the effects of OCM-related micronutrients on
As methylation capacity is limited by the facts that (a) there are profound differences between
species in As metabolism efficiency (both mice and rats are extremely efficient in As methylation);
(b) animals are less prone to developing As-related cancers than are humans; and (c) rodents are
much less prone to developing folate deficiency than are humans due to coprophagia. In addition,
it is challenging to mimic chronic, often decades-long, lower-dose population-based As exposure
levels using rodent models.
3.2. Human Studies on Folate and Arsenic Metabolism and Toxicity
Early human data suggesting a role for folate inAs toxicity came in the formof isolated case reports.
For example, an interesting case study of a girl deficient inMTHFR, the enzyme responsible for the
reduction of 5,10-methylene-THF to 5-methyl-THF, developed severe symptoms of As toxicity
following exposure to an As-containing pesticide, while no other exposed family members were
affected (19). Several studies on nutrition and As are summarized inTable 2. For example, in 2002,
Smith’s group (29) reported a cross-sectional study of 11 families exposed to As-contaminated
drinking water in Chile (N= 44) in which the correlations of As methylation patterns between
fathers and mothers were low, but they increased substantially with adjustment for folate and
Hcy, indicating that folate and Hcy are sources of variation in As methylation. Two years later,
Smith’s group (104) reported a nested case-control study of As-related skin lesions (keratosis and
melanosis) in a population with very high water As concentrations in West Bengal, India. While
they did not measure As metabolites, there was a positive trend in risk for skin lesions associated
with lower quintiles of folate intake (P for trend= 0.006). In a subsequent case-control study of this
population, diet was assessed using a 24-h recall, and the concentrations of selectedmicronutrients
were measured in serum; %MMAs was observed to be significantly lower among participants in
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the highest tertile of serum folate compared to the lowest tertile (10). This same group conducted
another study employing dietary questionnaires in As-exposed regions of the western United
States, in which they found that participants falling in the lower quartiles for dietary protein,
iron, zinc, and niacin had higher %MMAs and lower %DMAs in urine compared to the highest
quartile (141). While they found no significant associations with dietary folate intake, the study
was conducted years after mandatory fortification of cereals, breads, pastas, flours, and other grain
products in the US food supply with FA; therefore, all of the study participants likely had fairly
high folate intake.
Our group has conducted a series of studies in Bangladesh, a population with chronic As expo-
sure, to better characterize the interconnections between folate, As metabolism, and As toxicity.
We first conducted a cross-sectional study of As-exposed adults in Bangladesh, in which we
observed that plasma folate was negatively associated with%MMAs and positively associated with
%DMAs (50). We then studied the effect of 400-μg FA per day, the US recommended dietary
allowance, on As metabolism in a randomized, double-blind, placebo-controlled trial among 200
folate-deficient (plasma folate <9 nmol/L) Bangladeshi adults. After 12 weeks of supplementa-
tion, the treatment group had a significantly larger increase in %DMAs and decreases in %InAs
and %MMAs in urine relative to the placebo group; treatment effects were observed as early as
one week post-intervention (49). In addition, FA supplementation lowered blood As by 14% and
bloodMMAs by 22% (51).More recently, in the Folic Acid andCreatine Trial (FACT) conducted
among 622 As-exposed Bangladeshi adults selected independent of folate status, a larger decrease
in blood As was observed in the treatment group receiving 800-μg FA per day for 12 weeks rel-
ative to the placebo group (115). In addition, increases in As methylation capacity were observed
among the treatment groups receiving 800-μg FA per day and 400-μg FA per day relative to
placebo as measured by the change in %InAs, %MMAs, and %DMAs in urine between baseline
and week 12 (15). FACT included a 12-week wash-out period during which half of the partic-
ipants in the FA treatment groups were switched to placebo to examine the effects of cessation
of supplementation on As methylation. Arsenic metabolites reverted to pre-intervention levels
12 weeks after FA supplementation was discontinued, highlighting the importance of maintaining
adequate folate nutritional status over time. This has important policy implications, as prolonged
maintenance of FA effects may be more readily achieved through food FA-fortification programs
than through recommendations for over-the-counter FA supplements, as the latter has limited
long-term compliance.
In 2009, we reported the results of a nested case-control study of skin lesions (274 cases and
274 controls) in Bangladesh in which we found that low folate, hyperhomocysteinemia, and low
urinary creatinine were associated with risk for subsequent development of skin lesions after con-
trolling for age, urinary As, and use of betel nut (amild stimulant and known carcinogen commonly
chewed by Bangladeshi adults) (120). These findings are consistent with those of an analysis of
dietary folate and skin lesions in India by Smith and colleagues (104). Similar results were found
in relation to urothelial carcinoma. In a case–control study of 177 cases and 488 controls in a
population in Taiwan exposed to low concentrations of As in drinking water, higher %DMAs in
urine and higher plasma folate concentrations were associated with a decreased risk for urothelial
carcinoma. Furthermore, a significant interaction was observed between urinary As methylation
profiles and plasma folate in affecting urothelial carcinoma risk (73). More recently, in a larger
nested case-control study (N= 876 cases and 876 controls) of gene × nutrition × environment
interactions, hyperhomocysteinemia and lower %DMAs in urine were both associated with in-
creased risk for development of skin lesions 2–7 years later (113).We also found TYMS rs1001761
was associated with increased skin lesion risk at water As exposure >50 μg/L. The latter finding
highlights a potential role of OCM in As toxicity independent of As methylation. The TYMS
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gene encodes thymidylate synthetase, which utilizes 5,10-methylene-THF for the methylation of
2-deoxy-uridine-5-monophosphate (dUMP) to 2-deoxy-thymidine-5-monophosphate (dTMP)
and is critical for DNA synthesis and repair (Figure 4) (23). These findings raise the possibility
that DNA damage involving thymidylate synthetase may be a mechanism of As toxicity at higher
As concentrations. Consistent with this hypothesis, a recent study from the Stover group identi-
fied thymidylate biosynthesis as a sensitive target for As at levels observed in human populations
(As trioxide at 0.5 μM, equivalent to 75-μg/L As in water) (78). The study found that As exposure
to cell cultures impaired folate-dependent dTMP biosynthesis, resulting in uracil misincorpora-
tion into DNA and genomic instability. Further, folate deficiency exacerbated the impact of As
on uracil misincorporation and genomic instability, providing a potential additional mechanism
linking folate deficiency to skin lesion risk (78).
Recent, large epidemiological studies have confirmed our findings relating folate to As methyl-
ation, including in populations with lower As exposure. In a cross-sectional study of 1,027 women
in Mexico with a median urinary As of 25.9 μg/g creatinine, micronutrient intake was estimated
using a food frequency questionnaire; folate intake was associated with significantly lower %InAs
and higher methylation ratio of DMAs/InAs (96). In addition, in an analysis of the 2003–2004
National Health and Nutrition Examination Survey, dietary folate intake was negatively associ-
ated with urinary %InAs and positively associated with %DMAs in unadjusted models, and red
blood cell folate was negatively associated with%InAs in adjustedmodels (84). In the StrongHeart
Study, a cohort study of American Indian adults with low tomoderate As exposure, high combined
intake of folate and B6, as estimated by a food frequency questionnaire, was negatively associated
with %InAs in urine and positively associated with %DMAs (137). The significant associations
between dietary intake of folate and As metabolism in these studies differ from the results of a
dietary intake analysis by members of our group that reported no association with dietary folate
intake in Bangladesh (63). However, the prolonged cooking times traditionally used in Bangladesh
can degrade folate in foods, making it more difficult to accurately measure true folate intake. Such
considerations highlight the importance of using circulating folate concentrations, particularly in
this region of the world.
Several studies relating OCM to As methylation have been conducted in pregnant women.
During pregnancy, OCM influences exposure of the fetus to As, as InAs, MMAs, and DMAs
are all transported through the placenta. Furthermore, As concentrations and As metabolites are
similar in maternal and umbilical cord blood (31, 57). OCM is altered during pregnancy owing to
the demands of fetal development. For example, maternal plasma folate levels change dramatically
over the course of pregnancy. Additionally, endogenous choline synthesis is induced by estrogen
and upregulated during pregnancy and lactation (173).
The relationship betweenOCM-relatedmicronutrients andAsmetabolism in pregnantwomen
has been investigated in several studies. In a cross-sectional study of women at 14 weeks gestation
in Bangladesh (N= 753), Vahter’s group reported an inverse association between plasma folate
tertiles and urinary %InAs. Women who were deficient in folate, vitamin B12, and zinc had sig-
nificantly higher %InAs and lower primary methylation index (MMAs/InAs) compared to women
who were not deficient in any of the three nutrients (88). Vahter’s group conducted a subsequent
longitudinal study of Bangladeshi women (N= 324) assessed at gestational weeks 8, 14, and 30.
They observed significant negative associations between gestational week and urinary %InAs and
%MMAs, and a significant positive association between gestational age and %DMAs; however,
neither plasma folate nor B12 were associated with the proportions of As metabolites (53). The
conclusion that these micronutrients have little effect on As methylation during pregnancy may
be complicated by changes in OCM during pregnancy. In addition, all women received a daily
supplement of 400-μg FA beginning at week 14, which may have impacted As metabolism.
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3.3. Impact of Other OCM-Related Nutrients on Arsenic Methylation
Although the association between folate and As methylation has been broadly studied, other
micronutrients involved in OCM (Figure 4) may influence As methylation capacity. Below, we
summarize research on the associations between creatine, vitamin B12, choline, and betaine and
As methylation profiles in humans. These OCM micronutrients are less widely examined than
folate in terms of their relationship to Asmethylation, and are potential avenues for future research
directions.
3.3.1. Creatine. Creatine is a nitrogenous organic acid that is present in foods and is also syn-
thesized endogenously. Our group (15, 49, 50, 59) and others (10, 79) have consistently reported
that urinary creatinine, a degradation product of creatine, is a strong predictor of As methylation
capacity; it is positively associated with %DMAs in urine and negatively associated with %InAs.
The synthesis of creatine, the precursor of creatinine, consumes approximately 50% of all SAM-
derived methyl groups (106, 139). In omnivores, roughly half of creatine requirements are met
through dietary intake of creatine, primarily from meat (18). Urinary creatinine concentrations
therefore reflect both dietary creatine intake and endogenous creatine synthesis (18). Creatinine
is also commonly used in urinalyses to adjust for hydration status. Increases in circulating creatine
concentrations, e.g., from dietary intake, lower creatine biosynthesis by inhibiting synthesis of
guanidinoacetate (GAA), the precursor of creatine; in rodents, this has been shown to spare
methyl groups and lower Hcy (37, 56, 138, 149). We hypothesized that creatine supplementation
may also spare methyl groups and thereby facilitate the methylation of As, and may underlie the
observed associations between the proportion of urinary As metabolites and urinary creatinine.
We tested this hypothesis in our FACT study. Creatine supplementation for 12 weeks at 3 g
per day (roughly 1.5 times the normal daily creatine turnover for a 70-kg male) lowered GAA
as predicted, illustrating that creatine supplementation inhibited GAA synthesis (116). Also, the
mean decrease in urinary %MMAs in the creatine treatment group exceeded that of the placebo
group at weeks 6 and 12 (P < 0.05); however, creatine supplementation did not affect the change
in %InAs or %DMAs (15). Creatine treatment effects may have been tempered by long-range
allosteric regulation of OCM (see Section 3.5). Further research is needed to understand the
strong cross-sectional associations between urinary creatinine and As methylation in previous
studies. One possibility is that urinary creatinine is somehow related to renal tubular reabsorption
of InAs, a topic that is understudied in the scientific literature.
3.3.2. Vitamin B12 (cobalamin). Vitamin B12 has been inconsistently linked to As metabolism
in human studies, but has not been studied in animal models. In an early cross-sectional study
in Bangladesh in which we oversampled B12-deficient individuals, we found plasma B12 concen-
trations to be inversely associated with %InAs in urine and positively associated with %MMAs,
with no association with %DMAs (58). We found it difficult to reconcile a mechanism whereby
B12 would facilitate mono- but not dimethylation of As. To test whether this might have been a
spurious finding, we subsequently analyzed the relationship between B12 and As metabolites in
blood and urine in the FACT and FOX studies. In baseline samples from the FACT study, there
were no significant associations between B12 and As metabolites in urine (nonsignificant correla-
tions were negative for %InAs and %MMAs and positive for %DMAs), and all associations with
blood As metabolite concentrations were negative. In FOX, while B12 was positively associated
with %MMAs in urine (Spearman correlation coefficient ρ = 0.12, P= 0.02) the correlation with
MMAs concentrations in blood was null (Spearman correlation coefficient ρ =−0.02, P= 0.76)
(M.V. Gamble, unpublished data). In an analysis of the 2003–2004National Health andNutrition
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Examination Survey, in adjusted models, dietary B12 intake was positively associated with urinary
%InAs and negatively associated with %DMAs (84), but other studies have reported null results
(137) or contrasting directions of association (96). To date, no studies investigating the treatment
effects of B12 supplementation on As methylation have been published. Additional studies are
needed to better understand the relationship between B12 and As methylation.
3.3.3. Choline and betaine. The remethylation of homocysteine to methionine, critical for
the synthesis of SAM, can be catalyzed either by methionine synthase, which receives a methyl
group from5-methyl-THF, or by betaine homocysteinemethyltransferase, which utilizes amethyl
group from betaine. Thus, folate and betaine can be used interchangeably for the remethylation
of homocysteine. Betaine can be obtained through the diet or synthesized from choline. Choline
can also be obtained from the diet or it can be synthesized endogenously. Choline may serve
as a methyl donor through its conversion to betaine. However, endogenous choline synthesis,
like creatine, is another significant consumer of SAM, as roughly 30% is synthesized de novo
through a pathway that involves three sequential SAM-dependent methylation reactions catalyzed
by phosphatidylethanolamine N-methyltransferase (159).
Epidemiological studies of choline and As methylation are few, but their results are generally
consistent with animal studies (described in Section 3.1). In a cross-sectional analysis (N= 1,016)
nested within the Health Effects of Arsenic Longitudinal Study (HEALS), an ongoing cohort
in Bangladesh led by Habibul Ahsan, multiple nutrients were found to be associated with As
methylation. In multivariate adjusted models, dietary choline intake was positively associated
with the secondary methylation index (DMAs/MMAs) (63). In a subsequent study of women in
Mexico (described in Section 3.2), Lo´pez-Carrillo et al. (96) found that higher dietary choline is
inversely associated with %MMAs in urine and positively associated with %DMAs and secondary
methylation index. However, results from epidemiological studies indicate that dietary betaine
has a weaker association with As methylation than choline has. In the HEALS cohort as well as
Lo´pez-Carrillo et al.’s study of Mexican women, betaine intake was not associated with indicators
of As methylation capacity; however, both studies relied on estimates of betaine intake from food
frequency questionnaires without biological assessment of betaine status (63, 96).
Our group conducted an 8-week pilot intervention of choline (700 mg/day), betaine
(1,000 mg/day) or choline+ betaine supplementation in Bangladesh (N= 60).Within-participant
changes in %MMAs and %DMAs in urine were significantly different between groups receiving
choline, betaine, and choline + betaine (P < 0.05) as compared to placebo (M.N. Hall & M.V.
Gamble, unpublished data). Although the sample size was small, the data suggest that choline +
betaine supplementation resulted in the largest decrease in %MMAs and increase in %DMAs,
supporting the hypothesis that both dietary choline and betaine impact As methylation. Enthusi-
asm for larger intervention studies with choline and betaine has been tempered by the finding that
choline supplementation also increased plasma tri-methylamine oxide (TMAO). While TMAO
has been linked to risk for cardiovascular disease (150), it is unclear whether or not this relationship
is causal (174).
3.4. Impact of OCM-Related Polymorphisms
There is some evidence that polymorphisms in genes involved in OCM affect As methylation ca-
pacity. Our group has conducted several studies investigating the effect of OCM-related variants
on As methylation. As part of a case-control study of skin lesions in Bangladesh (594 cases and
1,041 controls), members of our group led by Habibul Ahsan investigated the effect of two SNPs
inMTHFR (rs1801133 and rs1801131). Neither As methylation profiles, nor risk for skin lesions,
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differed significantly between haplotypes or diplotypes (2). In a subsequent nested case-control
study of incident skin lesions in Bangladesh, we genotyped 26 SNPs in 13 OCM-related genes
(N= 876 matched pairs) (113). No SNPs achieved a statistically significant association with urine
As metabolite proportions at a false discovery rate (FDR)-corrected P < 0.05, although SNPs
in MTHFR, methionine synthase (MTR), and serine hydroxymethyltransferase 1 (SHMT1) were
nominally significant. The MTHFR rs1801133 T allele was associated with higher %MMAs and
lower %DMAs, and the MTR rs1805087 G allele and SHMT1 rs1979277 A allele were associ-
ated with higher %InAs. In addition, three SNPs [rs1540087 and rs7109250 in folate receptor
1 (FOLR1) and rs1801394 in methionine synthase reductase (MTRR)] had nominally significant
interactions with water As in logistic regression models predicting skin lesion risk; however, these
interactions were not significant after FDR correction. Our colleagues also genotyped 19,992 vari-
ants in 4,939 Bangladeshi individuals who were enrolled in theHEALS cohort and the Bangladesh
Vitamin E and Selenium Trial (BEST). The SNP rs61735836, located in the FTCD gene encod-
ing formimidoyltransferase cyclodeaminase (a bifunctional enzyme that channels one-carbon units
from formiminoglutamate to the folate pool), was associated with urinary %InAs, %MMAs, and
%DMAs, and the A allele was associated with an increased risk of skin lesions (B.L. Pierce, L.
Tong, M. Argos, F. Jasmine, M. Rakibuz-Zaman, et al., manuscript in review).
The association between OCM-related variants and As methylation capacity has also been
investigated by other groups. In 2007, Lindberg et al. also reported that the MTHFR rs1801133
T allele was associated with higher %MMAs and lower %DMAs in urine (93). In a study of
women in Argentina, SNPs inMTHFRwere not associated with Asmethylation. However, rs9001
located in CHDH (encoding choline dehydrogenase) was significantly associated with %MMAs
in urine (128). Smith’s group (121) also investigated the association between OCM-related SNPs
and As methylation in their case-control study of lung cancer in Argentina. This study found
that polymorphisms in MTHFR, MTR, SHMT1, TYMS, and DHFR (encoding dihydrofolate
reductase) were not associated with As metabolite proportions (121). One SNP in CBS (encoding
cystathionine-β-synthase), rs4920037, was significantly associated with %MMAs in urine.
3.5. Mathematical Models of OCM and Arsenic Methylation
Our collaborators, Michael C. Reed and H. Frederik Nijhout at Duke University, developed a
whole-body mathematical model of OCM that includes As absorption, storage, methylation, and
excretion to study and interpret the data on the effects of FA supplementation on As methylation
and excretion in our clinical trials in Bangladesh (https://sites.duke.edu/metabolism/arsenic/).
Parameters for hepatic As methylation were taken from the biochemical literature. The model
has compartments for the binding of arsenicals to intracellular proteins, which improve the fits
to data. Because transport parameters between tissues are largely unknown, they were adjusted
so that the model accurately predicted the urine excretion rates of InAs, MMAs, and DMAs in
single-dose experiments on human subjects. We then demonstrated that, with no further changes
in parameters, the model accurately predicts the time courses of urinary As excretion in multiple-
dose experiments conducted in human subjects. In our first trial of folate-deficient individuals, FA
supplementation decreased total blood As by 14%. This result was also produced by the model.
Furthermore, the model predicts that As in the liver will decrease by 19% and As in other body
stores by 26% (86).
We have also used the mathematical model of OCM to better understand the modest
changes observed with creatine supplementation in our FACT study. We asked the question:
If guanidinoacetate-N-methyltransferase flux goes down, how much might hepatic SAM in-
crease, and how much will that increase the flux through AS3MT? When one methyltransferase
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enzyme is downregulated, there are several long-range interactions that buffer the flux through
other methyltransferases. Thus, to increase As methylation, e.g., with creatine supplementation, it
would also be necessary to break one or more of those regulatory mechanisms. Because glycine-N-
methyltransferase (GNMT) regulates hepatic SAM concentrations and is inhibited by binding to
5-methyl-THF, increasing hepatic 5-methyl-THF concentrations should allow creatine supple-
mentation to increase SAM by inhibiting GNMT. However, while plasma folate concentrations
increase substantially with FA supplementation, it is unknown to what extent this supplementa-
tion causes liver folate and liver SAM to increase in folate-sufficient individuals (126). Thus, the
mathematical models of OCMhave helped us to better understand why the effects of creatine sup-
plementation on As methylation—while statistically significant—were modest (15). These models
can also be used to inform future nutritional interventions.
4. CONCLUSIONS AND FUTURE DIRECTIONS
Arsenic exposure via drinking water and food is a worldwide problem linked to a variety of adverse
health outcomes, including skin lesions, cardiovascular disease, impaired intellectual function,
inflammation, diabetes, and cancers of numerous organs. Methylation of As, which facilitates
urinary As excretion, is dependent on OCM. A number of micronutrients play important roles in
OCM, including folate, vitamin B12, pyridoxal phosphate, riboflavin, choline, and betaine. There
is strong evidence from epidemiological studies and randomized controlled trials to indicate that
folate status and FA supplementation influence As methylation capacity, enhance As elimination,
and lower blood As concentrations, particularly in populations living in regions without FA-
fortification programs. However, the literature is currently lacking sufficient information on the
influences of other micronutrients involved in OCM on As methylation, elimination, and toxicity.
Perhaps the most salient need for future research is to definitively establish that increasing As
methylation through nutritional interventions such as FA supplementation reduces risk for As-
related health outcomes. While results of nested case-control studies are highly suggestive that
this is true for As-related skin lesion risk, the data are not as definitive as randomized controlled
trial results. Furthermore, future studies are needed to establish possible protective effects of FA
for other As-related adverse health outcomes.
Currently,more than85 countries in theworld havemandatory foodFA-fortificationprograms.
As has been demonstrated in Western countries such as the United States and Canada, folate
fortification can nearly eradicate folate deficiency and many of its associated consequences. Yet of
those countries suffering the most widespread problems of As-contaminated drinking water, none
have mandatory FA-fortification programs. Clearly, access to safe drinking water is the highest
priority. However, in As-endemic countries, FA fortification not only may help to eradicate folate
deficiency, but may have the additional benefit of facilitating a partial reduction in the public
health consequences of As exposure.
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